⌘K

Login Start Free

Home/Filings/4/0001140361-17-045182

4//SEC Filing

Bultot Hugues 4

Accession 0001140361-17-045182

CIK 0001460602other

View on SEC.gov Company Profile

Filed

Dec 5, 7:00 PM ET

Accepted

Dec 6, 2:56 PM ET

Size

18.0 KB

Accession

0001140361-17-045182

Insider Transaction Report

Form 4

Period: 2015-06-18

Orgenesis Inc.ORGS

Director

Transactions

Exercise of In-Money
Common Shares
2017-11-17$356549.04/sh+2,452,751$874,526,014,409→ 7,127,090 total
Other
Common Shares
2017-01-16−376,115→ 4,674,339 total
Other
Stock Options
2017-01-16−197,357→ 2,452,751 total
From: 2015-03-02Exp: 2017-11-05→ Common Stock (197,357 underlying)
Award
Stock Options
2016-12-09$0.40/sh+500,000$200,000→ 750,000 total
Exercise: $0.40Exp: 2026-12-09→ Common Stock (500,000 underlying)
Exercise of In-Money
Stock Options
2017-11-17−2,452,751→ 0 total
Exercise: $0.15From: 2015-03-02Exp: 2017-11-05→ Common Stock (2,452,751 underlying)
Award
Stock Options
2015-06-18$0.53/sh+250,000$132,500→ 250,000 total
Exercise: $0.53From: 2015-06-18Exp: 2020-06-18→ Common Stock (250,000 underlying)

Holdings

Stock Options
From: 2015-03-02Exp: 2017-11-05→ Common Stock (2,650,108 underlying)
2,650,108
Common Shares
5,050,454

Footnotes (6)

[F1]As a result of the termination of the Masthercell SA's convertible note without conversion, the number of shares of common stock of Orgenesis Inc. (the "Issuer") received by Mr. Hugues Bultot as consideration for the purchase of Masthercell SA by the Issuer was reduced by 376,115 shares.
[F2]Under a private agreement Mr. Hugues Bultot had an option to purchase 2,650,108 shares of common stock of the Issuer from the Universite Libre de Bruxelles. As a result of the termination of the Masthercell SA's convertible note without conversion, the number of shares purchasable under the option was reduced by 197,357 shares.
[F3]The price per share was to be calculated on the basis of the total price for all shares taking into account the following formula: Total price for all shares = 750,000 EUR * (1 + 12.5%)N whereby N = the number of years after October 14, 2011, it being understood that in case the option is exercised before November 5, 2015 this number of years is increased by one.
[F4]On November 17, 2017, Mr. Bultot exercised the option to purchase 2,452,751 shares at an exercise price of $0.1454 per share from the Universite Libre de Bruxelles.
[F5]Vest quarterly over two years.
[F6]The information in this Form 4 does not reflect a reverse stock split of the Issuer's common stock at a ratio of 1-for-12, effective as of November 13, 2017.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

Orgenesis Inc.

CIK 0001460602

Entity typeother

Related Parties

1

filerCIK 0001636398

Filing Metadata

Form type: 4
Filed: Dec 5, 7:00 PM ET
Accepted: Dec 6, 2:56 PM ET
Size: 18.0 KB

View on SEC.gov